Stock CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Celldex: Q1 Earnings Snapshot
AQ
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000
MT
Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
MT
Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise
MT
Celldex Therapeutics : Corporate Presentation
PU
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
AQ
Celldex Therapeutics, Inc. Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
CI
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
AQ
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
AQ
Celldex Therapeutics to Present at TD Cowen's 44th Annual Health Care Conference
AQ
Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
AQ
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
AQ
Celldex Therapeutics Prices $400.4 Million Common Stock Offering
MT
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
AQ
Celldex Therapeutics Proposes $250 Million Underwritten Common Stock Offering
MT
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
AQ
Sector Update: Health Care Stocks Weaker Monday Afternoon
MT
Celldex Therapeutics Shares Rise After Q4 Revenue Tops Estimates
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. Stock
  5. News Celldex Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW